Latest Strategy News

Red Mountain Mining has revealed a technical study highlighting significant silver, gold, and antimony prospectivity at its Silver Dollar Project in Idaho, with exploration set to begin imminently.

South Harz Potash has submitted three new exploration licence applications in Sweden’s Värmland Province, significantly expanding its copper-gold project area near the existing Glava 100 site.

Verity Resources has wrapped up a major 10,860-metre drilling program at its Monument Gold Project, aiming to upgrade and expand its gold resource in Western Australia’s Laverton Goldfields.

ARC Funds Limited has completed a $737,750 equity placement, issuing new shares with free attaching unlisted call options to investors and its Managing Director. The funds will support working capital and debt reduction as the company advances its growth strategy.

Locksley Resources has launched an Expression of Interest process to select a leading U.S. engineering firm for the Desert Antimony Mine pilot plant design, marking a critical step toward establishing a domestic antimony supply chain aligned with federal priorities.

Ore Resources Ltd has raised A$7.5 million through an oversubscribed equity placement to accelerate gold exploration at its Coolgardie and Randalls projects in Western Australia. The funds will underpin an expanded drilling program targeting key prospects in 2026.

Atomic Eagle Limited announces Phil Hoskins as new CEO following Daniel Major's unexpected non-start, spotlighting the Muntanga Uranium Project's substantial resource base.

MRG Metals has reported strong laboratory results from 37 auger drillholes at its Adriano Rare Earth Project in Mozambique, confirming significant alluvial deposits with Total Heavy Mineral grades up to 9.56%. These findings bolster the potential for a district-scale rare earth system across the Adriano–Fotinho corridor.

Aumake Limited has raised $1.5 million through a share placement to strengthen inventory and expand its footprint in China, signaling renewed growth ambitions under a refreshed board.

Argenica Therapeutics’ AI-powered reanalysis of its Phase 2 trial reveals significant efficacy of ARG-007 in severe acute ischemic stroke patients, highlighting improved functional outcomes and reduced brain damage.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Pantera Minerals has launched trading on the OTCQB Venture Market under ticker PTMLF, broadening its reach to U.S. investors and advancing its critical minerals exploration in Arkansas. This move complements its ASX listing and positions the company at the forefront of America’s push for secure domestic supply chains.